-
Mashup Score: 0Avoiding the Digital Age is Hurting Research Efforts - 1 day(s) ago
A greater shift from paper records and physical assets is achievable.
Source: www.pharmexec.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2The Real Cost of State Drug Importation Programs? Patient Safety - 20 day(s) ago
Importing drugs from Canada may increase the risk of US citizens being exposed to unsafe medicines.
Source: www.pharmexec.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0At-Home Patients and AI: Q&A with Riccardo Butta - 27 day(s) ago
Butta discusses how new technologies are being implemented in at-home devices.
Source: www.pharmexec.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 5Researchers Present First Study Using Biomimetic AI Digital Twins - 2 month(s) ago
The study used technology developed by a variety of companies, including RYLTI.
Source: www.pharmexec.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0
In this Pharmaceutical Executive video interview, Daniel Ayala, Chief Security and Trust Officer, Dotmatics, discusses data security threats from human error to AI tech and how COVID-19 impacted data integrity.
Source: www.pharmexec.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0
Early-stage trial results indicate that NLRP3 inflammasome inhibitors were able to achieve nearly the same weight loss as Wegovy while also reducing inflammatory biomarkers linked to heart disease.
Source: www.pharmexec.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6FDA Updates Label for Regeneron's Dupixent in Atopic Dermatitis With Uncontrolled Hand and Foot Involvement - 4 month(s) ago
Dupixent is an IL-4 receptor alpha antagonist that has been approved for the treatment of adults with moderate-to-severe atopic dermatitis, as well as asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, and prurigo nodularis.
Source: www.pharmexec.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 1The Price of Prescriptions: Getting it Right - 5 month(s) ago
Drug companies face new hurdles in a rapidly changing marketplace. How do they finance new drug development amid the uncertainty?
Source: www.pharmexec.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 3Artificial Intelligence Changing the Landscape for Healthcare Social Media Marketing - 5 month(s) ago
Experts from Hootsuite noted that the primary social media ROI concern for healthcare companies is the time and money it takes to maintain a multi-platform presence.
Source: www.pharmexec.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2FDA Approves CorMedix Inc’s Treatment for Bloodstream Infections in Patients Receiving Dialysis - 6 month(s) ago
Defencath is indicated for the prevention and treatment of catheter-related bloodstream infections in adults with kidney failure administered chronic hemodialysis via a central venous catheter.
Source: www.pharmexec.comCategories: General Medicine News, Hem/OncsTweet
Avoiding the Digital Age is Hurting Research Efforts https://t.co/CkzmKeXWue https://t.co/2hOV4M3bQg